Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma

References

Page 1

	Year	Citations
‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Ruxandra Gref, Martín Luck, P. Quellec, Colloids and Surfaces B Biointerfaces NanoparticlesProtein CoronaEngineeringNanomaterialsPlasma Protein Adsorption	2000	1.7K
Transferrin receptor on endothelium of brain capillaries Wilfred A. Jefferies, Malcolm R. Brandon, Simon V. Hunt, Nature NeurophysiologyMedicinePhysiologyEndothelial DysfunctionVascular Biology	1984	1.1K
Biodegradable poly(lactic acid) polymers R. K. Kulkarni, Evan G. Moore, Andrew F. Hegyeli, Journal of Biomedical Materials Research EngineeringDegradable PlasticDl ‐Lactic AcidPolymer StabilityLactic Acids	1971	795
Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier Jordan B. Fishman, Joshua B. Rubin, J. V. Handrahan, Journal of Neuroscience Research	1987	537
Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery Pilar Calvo, Bruno Gouritin, Hélène Chacun, Pharmaceutical Research	2001	442
Human blood-brain barrier transferrin receptor William M. Pardridge, Jody Eisenberg, Jing Yang Metabolism Blood–brain BarrierNeuropeptide ReceptorNeuroscienceMolecular NeurobiologyCerebral Vascular Regulation	1987	356
Synthesis of high‐molecular‐weight poly(<scp>L</scp>‐lactide) initiated with tin 2‐ethylhexanoate Jan W. Leenslag, A. J. Pennings Die Makromolekulare Chemie Polymerization TemperatureEngineeringHigh‐molecular‐weight PolyPolymer NanocompositesChemistry	1987	282
Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting Irène Brigger, Jackie Morizet, Geneviève Aubert, Journal of Pharmacology and Experimental Therapeutics	2002	231
Rationale for Design of Biologically Reversible Drug Derivatives: Prodrugs A.A. Sinkula, Samuel H. Yalkowsky Journal of Pharmaceutical Sciences Medicinal ChemistryPharmaceutical ScienceDrug DesignMedicineNatural Sciences	1975	223
Surface-engineered nanoparticles for multiple ligand coupling Ruxandra Gref, Patrick Couvreur, Gillian Barratt, Biomaterials NanoparticlesEngineeringSurface FunctionalizationNanomaterialsNanotechnology	2003	192

Page 1